These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12061997)

  • 1. [Usefulness of cytosolic tissue-type plasminogen activator levels in lung adenocarcinomas].
    Ruibal A; Núñez MI; Del Río MC; Rodríguez J; Alvarez De Linera JF
    Med Clin (Barc); 2002 Jun; 119(1):1-3. PubMed ID: 12061997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
    Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
    Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung.
    Ruibal A; Nuñez MI; Rodríguez J; Jiménez L; del Rio MC; Zapatero J
    Int J Biol Markers; 2003; 18(3):188-94. PubMed ID: 14535589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CYFRA 21.1 cytosol levels in lung adenocarcinomas. Correlation with other clinico-biological parameters].
    Ruibal A; Núñez MI; Del Río MC; Lapeña G; Rodríguez J
    Rev Esp Med Nucl; 2002; 21(5):333-7. PubMed ID: 12236907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CA125 cytosolic levels in lung adenocarcinomas. New biological aspects].
    Ruibal A; Nuñez Cambre I; Sánchez Salmón A; Nuñez MI; Rodríguez J
    Rev Esp Med Nucl; 2005; 24(1):27-31. PubMed ID: 15701343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CD44s Cell surface expression in 55 lung adenocarcinomas. Negative correlation with tumor size and CA125 cytosolic levels].
    Ruibal A; Núñez MI; del Río MC; Pardo C; Rodríguez J
    Rev Esp Med Nucl; 2003; 22(2):82-6. PubMed ID: 12646096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
    Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
    Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytosolic cathepsin D levels in squamous carcinomas of the lung].
    Ruibal A; Núñez MI; Río Mdel C; García Díez S; Rodríguez J; Alvarez de Linera JF
    Med Clin (Barc); 2003 Feb; 120(3):81-4. PubMed ID: 12605727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological grade in breast cancer: association with clinical and biological features in a series of 229 patients.
    Ruibal A; Arias JI; Del Río MC; Lapeña G; Schneider J; Tejerina A
    Int J Biol Markers; 2001; 16(1):56-61. PubMed ID: 11288957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer.
    Corte MD; González LO; Lamelas ML; Alvarez A; Junquera S; Allende MT; García-Muñiz JL; Argüelles J; Vizoso FJ
    Breast Cancer Res Treat; 2006 Jun; 97(3):329-37. PubMed ID: 16791488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination.
    Nagayama M; Sato A; Hayakawa H; Urano T; Takada Y; Takada A
    Cancer; 1994 Mar; 73(5):1398-405. PubMed ID: 8111706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the tissue plasminogen activator as a prognostic and differentiation factor in patients with pancreatic cancer and chronic pancreatitis.
    Baluka D; Urbanek T; Lekstan A; Swietochowska E; Wiaderkiewicz R; Kajor M; Jedrzejewska-Szypulka H; Kusnierz K; Lampe P
    J Physiol Pharmacol; 2016 Feb; 67(1):93-101. PubMed ID: 27010898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer.
    Yamashita J; Ogawa M; Yamashita S; Nakashima Y; Saishoji T; Nomura K; Inada K; Kawano I
    Br J Cancer; 1993 Sep; 68(3):524-9. PubMed ID: 8394731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Biological Significance of Cathepsin D Levels in Breast Cancer Cytosol in Women Over 70 years.
    Ruibal A; Herranz M; Arias JI
    Biomark Cancer; 2012; 4():1-6. PubMed ID: 24179390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
    Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S
    Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.
    Steiner E; Pollow K; Hasenclever D; Schormann W; Hermes M; Schmidt M; Puhl A; Brulport M; Bauer A; Petry IB; Koelbl H; Hengstler JG
    Gynecol Oncol; 2008 Mar; 108(3):569-76. PubMed ID: 18222533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen Activation System in Rectal Adenocarcinoma.
    Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
    De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
    Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
    de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Lamers CB
    Cancer Res; 1987 Sep; 47(17):4654-7. PubMed ID: 3621160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell membrane CD44v6 levels in squamous cell carcinoma of the lung: association with high cellular proliferation and high concentrations of EGFR and CD44v5.
    Ruibal Á; Aguiar P; Del Río MC; Nuñez MI; Pubul V; Herranz M
    Int J Mol Sci; 2015 Feb; 16(3):4372-8. PubMed ID: 25809603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.